Amyloid-尾 is a central endogenous pathogen in Alzheimer's disease (AD).
Soluble A尾 oligomers are the major cause of synaptotoxicity/neurodegeneration in AD.
Bexarotene administration has been proposed as a potential treatment for AD.
Bexarotene administration had no effects on histology or electrophysiology.
Bexarotene administration had no effects on A尾-induced cognitive decline.